These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26168629)

  • 1. [Analysis of reimbursement of dialysis patients' transport expenses in Lorraine].
    Allenbach D; Pereira O
    Sante Publique; 2015; 27(1 Suppl):S155-65. PubMed ID: 26168629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cost of dialysis and kidney transplantation in France in 2007, impact of an increase of peritoneal dialysis and transplantation].
    Blotière PO; Tuppin P; Weill A; Ricordeau P; Allemand H
    Nephrol Ther; 2010 Jul; 6(4):240-7. PubMed ID: 20554257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost of dialysis in France].
    Benain JP; Faller B; Briat C; Jacquelinet C; Brami M; Aoustin M; Dubois JP; Rieu P; Behaghel C; Duru G
    Nephrol Ther; 2007 Jun; 3(3):96-106. PubMed ID: 17540311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
    Lee H; Manns B; Taub K; Ghali WA; Dean S; Johnson D; Donaldson C
    Am J Kidney Dis; 2002 Sep; 40(3):611-22. PubMed ID: 12200814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements.
    Lamas Barreiro JM; Alonso Suárez M; Saavedra Alonso JA; Gándara Martínez A
    Nefrologia; 2011; 31(6):656-63. PubMed ID: 22130280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for an incentive-based reimbursement policy toward quality care for dialysis patient management.
    Hidai H
    Kidney Int; 2000 Jul; 58(1):363-73. PubMed ID: 10886583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Report on chronic dialysis in France in 2016].
    Société Francophone de Néphrologie Dialyse Et Transplantation
    Nephrol Ther; 2017 Apr; 13(2):105-126. PubMed ID: 28284824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of costs of health insurance, substitution therapy in chronic renal insufficiency].
    Chanut C; Barnouin F; Benech JM; Bouvier P; Briat C; Hecht M; Pollini J; Soutif C; Toselli A
    Rev Epidemiol Sante Publique; 1991; 39(4):353-64. PubMed ID: 1754701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost of hemodialysis in Iran.
    Arefzadeh A; Lessanpezeshki M; Seifi S
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):307-11. PubMed ID: 19237828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of dialysis treatments for end-stage renal disease (ESRD).
    Goeree R; Manalich J; Grootendorst P; Beecroft ML; Churchill DN
    Clin Invest Med; 1995 Dec; 18(6):455-64. PubMed ID: 8714789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage renal disease and chronic kidney disease in Brazil.
    Lugon JR
    Ethn Dis; 2009; 19(1 Suppl 1):S1-7-9. PubMed ID: 19484865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.
    Rodríguez-Carmona A; Perez Fontán M; Bouza P; García Falcón T; Valdés F
    Adv Perit Dial; 1996; 12():93-6. PubMed ID: 8865880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of ESRD treated with renal dialysis in France in 2003.
    Macron-Noguès F; Vernay M; Ekong E; Thiard B; Salanave B; Fender P; Allemand H
    Am J Kidney Dis; 2005 Aug; 46(2):309-15. PubMed ID: 16112050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Self dialysis: a new method of treatment for end-stage renal disease].
    Fournier G; Gaillard JL; Matha N; Man NK
    Nephrologie; 1984; 5(3):115-8. PubMed ID: 6493429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International study of health care organization and financing: development of renal replacement therapy in Germany.
    Kleophas W; Reichel H
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):185-200. PubMed ID: 17701342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factor and cost accounting analysis for dialysis patients in Taiwan.
    Su BG; Tsai KL; Yeh SH; Ho YY; Liu SY; Rivers PA
    Health Serv Manage Res; 2010 May; 23(2):84-93. PubMed ID: 20424276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in dialysis treatment modalities during institution of flat rate reimbursement and quality assurance programs.
    Kleophas W; Karaboyas A; Li Y; Bommer J; Reichel H; Walter A; Icks A; Rump LC; Pisoni RL; Robinson BM; Port FK
    Kidney Int; 2013 Sep; 84(3):578-84. PubMed ID: 23636176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs of dialysis in the USA.
    Garella S
    Nephrol Dial Transplant; 1997; 12 Suppl 1():10-21. PubMed ID: 9075223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Study of Health Care Organization and Financing for end-stage renal disease in France.
    Durand-Zaleski I; Combe C; Lang P
    Int J Health Care Finance Econ; 2007 Sep; 7(2-3):171-83. PubMed ID: 17680359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.